News Sort by Year All Years 2023 (4) 2022 (31) 2021 (33) 2020 (37) 2019 (7) 2018 (4) Search March 7, 2023 TFF Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results March 6, 2023 TFF Pharmaceuticals to Participate in the 35th Annual Roth Conference February 8, 2023 TFF Pharmaceuticals Appoints Harlan Weisman, M.D. as Permanent Chief Executive Officer January 9, 2023 TFF Pharmaceuticals Announces the Appointment of Zamaneh Mikhak, M.D. as Chief Medical Officer December 5, 2022 TFF Pharmaceuticals Announces Leadership Transition November 29, 2022 TFF Pharmaceuticals Announces Closing of $12.3 Million Public Offering November 18, 2022 TFF Pharmaceuticals Prices $10.675 Million Offering of Common Stock and Warrants November 17, 2022 TFF Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants November 14, 2022 TFF Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update November 7, 2022 TFF Pharmaceuticals to Hold Third Quarter 2022 Financial and Business Results Conference Call on November 14, 2022